Cargando…
Is the serum level of survivin, an antiapoptotic protein, a potential predictive and prognostic biomarker in metastatic pancreatic cancer?
In the present study, we aimed to assess the association between the serum survivin level and overall survival and treatment response rates in metastatic pancreatic cancer (MPC). Serum samples were prospectively collected from 41 patients with newly diagnosed MPC patients and 41 healthy individuals...
Autores principales: | Demirci, Nebi Serkan, Çavdar, Eyyüp, Erdem, Gokmen Umut, Hatipoglu, Engin, Celik, Emir, Sezer, Sevilay, Yolcu, Ahmet, Dogan, Mutlu, Seber, Erdogan Selcuk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10289789/ https://www.ncbi.nlm.nih.gov/pubmed/37352081 http://dx.doi.org/10.1097/MD.0000000000034014 |
Ejemplares similares
-
A logarithmic model for hormone receptor-positive and breast cancer patients treated with neoadjuvant chemotherapy
por: Şeber, Erdoğan Selçuk, et al.
Publicado: (2023) -
Antiapoptotic Molecule Survivin in Transplantation: Helpful or Harmful?
por: Assadiasl, Sara, et al.
Publicado: (2018) -
A Modified Epirubicin and Oxaliplatin Plus Capecitabine (EOX) Regimen as a Second- Line Therapy in Patients with Advanced Gastric Cancer
por: Bozkaya, Yakup, et al.
Publicado: (2018) -
Expression of SIRT1 and survivin correlates with poor prognosis in esophageal squamous cell carcinoma
por: Yan, Li, et al.
Publicado: (2020) -
Is plasma caveolin-1 level a prognostic biomarker in metastatic pancreatic cancer?
por: Demirci, Nebi S., et al.
Publicado: (2017)